Veeva Systems VEEV 深 滬
等待開盤 11-04 09:30:00 美东时间
303.21
-3.790
-1.23%
華盛通- 最 高306.55
- 今 開303.00
- 成交量 141.97万股
- 最 低 299.02
- 昨 收 307.00
- 總市值 4909.24万
- 52周最高 325.99
- 市盈率 靜 55.71
- 換手率 0.88%
- 52周最低 148.05
- 委 比 -33.33%
- 總股本 0.00亿
- 歷史最高 343.96
- 量 比 0.97
- 振 幅 2.45%
- 歷史最低 17.11
- 每 手 1
- 風險率 48.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Omnicom Appoints Tom Schwenger as CEO of Omnicom Health Marketing
Schwenger to drive accelerated growth, innovation and AI for Omnicom's clients amid rapid healthcare market evolution NEW YORK, Nov. 2, 2026 /PRNewswire/ -- Omnicom (NYSE: OMC), the world's ...
11-02 22:30
Analysts’ Top Healthcare Picks: Veeva Systems (VEEV), Abbott Laboratories (ABT)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
11-01 01:30
美股大行评级 | 潜在涨幅163.5%！BTIG上调Cullinan Therapeutics目标价至41美元，维持"买入"评级
今日重点评级关注：BTIG：维持Cullinan Therapeutics"买入"评级，目标价从40美元升至41美元；Rosenblatt：维持SK海力士"买入"评级，目标价从320美元升至400美元
10-29 12:30
ServiceNow To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc raised the price target for Reliance Inc (NYSE:RS) from $421 to $437. Keybanc analyst Samuel McKinney ...
10-26 20:58
Baird Maintains Outperform on Veeva Systems, Raises Price Target to $350
Baird analyst Joe Vruwink maintains Veeva Systems (NYSE:VEEV) with a Outperform and raises the price target from $300 to $350.
10-26 19:16
Veeva Systems Inc. Class A收涨0.62%，成交额4.62亿美元
10月23日，Veeva Systems Inc. Class A（VEEV）收涨0.62%，报322.55美元，成交额4.62亿美元，市值522.25亿美元...
10-23 04:37
美股大行评级 | 潜在涨幅523.44%！HC Wainwright & Co.上调Annexon目标价至25美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Annexon"买入"评级，目标价从14美元升至25美元；HC Wainwright & Co.：维持Alto Neuroscience"买入"评级，目标价从55美元升至60美元
10-20 12:36
$1000 Invested In Veeva Systems 10 Years Ago Would Be Worth This Much Today
Veeva Systems (NYSE:VEEV) has outperformed the market over the past 10 years by 9.08% on an annualized basis producing an average annual return of 22.87%. Currently, Veeva Systems has a market capitalization of $47.90 billion. Buying $1000 In VEEV: If an investor had bought $1000 of VEEV stock 10 ye...
10-14 07:45
IQVIA Selects Veeva Clinical Operations Applications
RESEARCH TRIANGLE PARK, N.C. and PLEASANTON, Calif., Oct. 13, 2026 /PRNewswire/ -- IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced an expansion of their partnership with the...
10-13 19:03
Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development
More than 175 biotechs use pre-configured applications to streamline operations PLEASANTON, Calif., Oct. 7, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 175...
10-07 19:03
